Evaluation of Serum Interleukin 35 and Interleukin 38 and Electrolyte Level in the Sera of Rheumatoid Arthritis and Osteoarthritis Iraqi Females
DOI:
https://doi.org/10.23851/mjs.v35i3.1393Keywords:
Rheumatoid arthritis, Osteoarthritis, IL-35, IL-38, Autoimmune diseaseAbstract
Background: Rheumatoid arthritis (RA), is a disease that happened because autoimmune and inflammatory effects, it is mean that the human immune system offence healthy cells in the body mistakenly, resulting in inflammation (swelling) in the impacted portions of the body. Osteoarthritis (OA) is treated as the most famous form of joint arthritis. Objective: It is a slowly developed, disabling joint problem that decrease quality of life (QOL) and affects 14% of adults ages 25 and older and nearly 34% of those ages 65 and older. Interleukin elevation levels have been linked to autoimmune and degenerative diseases, thus in the current study. Methods: We tried to evaluate the level of interleukins (IL-35 and IL-38) in the two diseases and found the relationship between immune system response and disease severity. Three groups (RA, OA and control) have been used in the study. Results: The comparison between the three groups has been done and the results show a high significant increase in the level of IL-35 and IL-38 in both patients groups (RA and OA) as compared with control (p<0.001). Furthermore, a highly significant (p<0.001) elevated Na level with a significant (p<0.001) decrease in K and Ca levels was found in the RA and OA patients compared with the control. Conclusions: The study shows that the rise in the levels of IL-35 and IL-38 declares the instinctive role of interleukins and the immune system in the regulation and severity of RA and OA diseases, the role of this parameter may be clear in the controlling and monitoring the progression of diseases.
Downloads
References
C. VanAtta and L. Perry, "Guiding osteoarthritis management," US Pharm, vol. 48, no. 3, pp. 17-21, 2023.
K. Burns, "Mobility matters: Nutritional management of canine joint disease," Vetted, vol. 115, no. 7, 2020.
H. Long, Q. Liu, H. Yin, K. Wang, N. Diao, Y. Zhang, J. Lin, and A. Guo, "Prevalence trends of site-specific osteoarthritis from 1990 to 2019: Findings from the global burden of disease study 2019," Arthritis & Rheumatology, vol. 74, no. 7, pp. 1172-1183, 2022.
A. Patel and D. Jani, "Exploration of hidden remedies to counter autoimmune diseases (rheumatoid arthritis)," International Journal of Ayurvedic and Herbal Medicine, vol. 10, no. 1, pp. 3709-3716, 2020.
S. Gautam, U. Kumar, and R. Dada, "Yoga and its impact on chronic inflammatory autoimmune arthritis,"Frontiers in Bioscience-Elite, vol. 13, no. 1, pp. 77-116, 2020.
N. Nelson, Imaging of Joint and Tendon Diseases. 2023, p. 104.
M. C. Bruno, M. C. Cristiano, C. Celia, N. D'Avanzo, A. Mancuso, D. Paolino, J. Wolfram, and M. Fresta, "Injectable drug delivery systems for osteoarthritis and rheumatoid arthritis," ACS Nano, 2022.
M. Sanger and T. Greenbowe, "Students' misconceptions in electrochemistry regarding current flow in electrolyte solutions and the salt bridge," Journal of Chemical Education, vol. 74, no. 7, p. 819, 1997.
B. Downs, M. Bagchi, B. Morrison, J. Galvin, S. Kushner, and D. Bagchi, "Development and utilization of a novel prodosomed-electrolyte and phytochemical formulation technology to restore metabolic homeostasis," in Metal Toxicology Handbook, CRC Press, 2020, pp. 67-80.
J. Mears, The Cell and Tissues. Routledge, 2020, pp. 63-96.
P. Uciechowski and W. Dempke, "Interleukin-6: A master player in the cytokine network," Oncology, vol. 98, no. 3, pp. 131-137, 2020.
E. Tait Wojno, C. Hunter, and J. Stumhofer, "The immunobiology of the interleukin-12 family: Room for discovery,"Immunity, vol. 50, no. 4, pp. 851-870, 2019.
C. Cornelissen, J. Lüscher-Firzlaff, J. M. Baron, and B. Lüscher, "Signaling by il-31 and functional consequences," European Journal of Cell Biology, vol. 91, no. 6-7, pp. 552-566, 2012.
C. Egwuagu, C.-R. Yu, L. Sun, and R. Wang, "Interleukin 35: Critical regulator of immunity and lymphocyte mediated diseases," Cytokine & Growth Factor Reviews, vol. 26, no. 5, pp. 587-593, 2015.
C. A. Dinarello, "Historical insights into cytokines," European Journal of Immunology, vol. 37, no. Suppl 1, S34-S45, 2007.
D. Sawant, K. Hamilton, and D. Vignali, "Interleukin-35: Expanding its job profile," Journal of Interferon & Cytokine Research, vol. 35, no. 7, pp. 499-512, 2015.
D. George and P. Mallery, IBM SPSS Statistics 26 Step by Step: A Simple Guide and Reference. Routledge, 2019.
R. Khadim and F. Al-Fartusie, "Evaluation of some trace elements and antioxidants in sera of patients with rheumatoid arthritis: A case-control study," Clinical Rheumatology, vol. 42, no. 1, pp. 55-65, 2023.
R. Staszkiewicz, D. Sobański, U. Ulasavets, J. Wieczorek, E. Golec, W. Marcol, and B. O. Grabarek, "Evaluation of the concentration of selected elements in serum patients with intervertebral disc degeneration," Journal of Trace Elements in Medicine and Biology, vol. 77, p. 127 145, 2023.
M. A. Mahdi, M. T. Mohammed, A. M. N. Jassim, and A. I. Mohammed, Phytochemical content and anti-oxidant activity of hylocereus undatus and study of toxicity and the ability of wound treatment, 2018.
D. Sheanair, M. Abdul-Mounther, M. Murshd, K. H Alshaheen, and Y. G Omran, "The relationship between serum potassium levels and some chemical limitations in rheumatoid arthritis from qurna district, basrah city," Journal of Kerbala University, vol. 6, no. 4, pp. 197-203, 2010.
R. Staszkiewicz, K. BryA, D. GAadysz, M. Gralewski, M. Garczarek, M. GadzieliAski, J. Wieczorek, W. Marcol, A. Ostenda, and B. O. Grabarek, "Changes in elements and relationships among elements in intervertebral disc degeneration," International Journal of Environmental Research and Public Health, vol. 19, no. 15, p. 9042, 2022.
M. Stroud, H. Duncan, and J. Nightingale, "Guidelines for enteral feeding in adult hospital patients," Gut, vol. 52, no. suppl 7, pp. vii1-vii12, 2003.
A. Al-Gebori, M. Alosami, and N. Al-Hashimi, "Prevalence of 25-hydroxy vitamin d deficiency and some biochem ical parameters in iraqi patients with rheumatoid arthritis and their associations with disease activity," Asian Journal of Pharmaceutical and Clinical Research, vol. 13, no. 4, 2020.
Z. Al-Sarray, R. Hussein, A. Al-Hafidh, and I. Al-Rayahi, "Vitamin d deficiency associates with disease severity in rheumatoid arthritis patients," Al-Mustansiriyah Journal of Science, vol. 33, no. 5, pp. 33-38, 2023.
N.-B. Tudorachi, luliana Eva, C. G. Dascalu, R. AL-Hiary, B. Barbieru, M. Paunica, C. Motofei, and A.-C. Moraru, "The influence of serum calcium and magnesium levels in the radiological evolution of knee osteoarthritis," Journal of Mind and Medical Sciences, vol. 7, no. 2, pp. 217-226, 2020.
P. Xin, L. Jie, Q. Cheng, D. Bin, and C. Dan, "Pathogenesis and function of interleukin-35 in rheumatoid arthritis," Frontiers in Pharmacology, vol. 12, p. 655 114, 2021.
A. Sharabi, M. Tsokos, Y. Ding, T. Malek, D. Klatzmann, and G. Tsokos, "Regulatory t cells in the treatment of disease," Nature Reviews Drug Discovery, vol. 17, no. 11, pp. 823-844, 2018.
L.-C. Su, X.-Y. Liu, A.-F. Huang, and W.-D. Xu, "Emerging role of il-35 in inflammatory autoimmune diseases," Autoimmunity Reviews, vol. 17, no. 7, pp. 665-673, 2018.
M. Filková, Z. Vernerová, H. Hulejová, K. Prajzlerová, D. Veigl, K. Pavelka, J. Vencovskỳ, and L. Šenolt, "Pro inflammatory effects of interleukin-35 in rheumatoid arthritis," Cytokine, vol. 73, no. 1, pp. 36-43, 2015.
L. Šenolt, B. Šumová, R. Jandová, H. Hulejová, H. Mann, K. Pavelka, J. Vencovskỳ, and M. Filková, "Interleukin 35 synovial fluid levels are associated with disease activity of rheumatoid arthritis," PloS One, vol. 10, no. 7, e0132674, 2015.
W.-D. XXu, L.-C. Su, C.-S. He, and A.-F. Huang, "Plasma interleukin-38 in patients with rheumatoid arthritis,"International Immunopharmacology, vol. 65, pp. 1-7, 2018.
Z. Hao and Y. Liu, "Il-38 and il-36 target autophagy for regulating synoviocyte proliferation, migration, and invasion in rheumatoid arthritis," Disease Markers, vol. 2021, 2021.
M. Abassifard, H. Khorramdelazad, S. Rezaee, and A. Jafarzadeh, "Higher circulating concentration of interleukin 38 in patients with knee osteoarthritis: Its association with disease severity," Iranian Journal of Allergy, Asthma and Immunology, vol. 20, no. 1, p. 114, 2021.
L. Mercurio, M. Morelli, C. Scarponi, E. Z. Eisenmesser, N. Doti, G. Pagnanelli, E. Gubinelli, C. Mazzanti, A. Cavani, M. Ruvo, C. A. Dinarello, C. Albanesi, and S. Madonna, "Il-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-il-17a treatment," Cell Death & Disease, vol. 9, no. 11, p. 1104, 2018.
Downloads
Key Dates
Received
Revised
Accepted
Published
Data Availability Statement
None.
Issue
Section
License
Copyright (c) 2024 Montadher Ali Mahdi, Mustafa Taha Mohammed, Nisred K. Klichkhanov
This work is licensed under a Creative Commons Attribution 4.0 International License.
(Starting May 5, 2024) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
How to Cite
